The emerging treatment of this peptide represents a significant development in the care of the condition. Unlike existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – providing enhanced https://tirzepatidepeptide311080.csublogs.com/49958169/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment